Synchrony utilizes a variety of neuromodulation technologies. Each of these is effective, non-invasive and without adverse side effects. Expert clinical judgment in applying these neuroscience technologies may reveal a previously undetected diagnosis or impairment, as well as “signature response patterns”, which inform therapeutic strategy.
The use of neuroscience technologies has enhanced the understanding and treatment of insufficient response to traditional treatments for psychiatric conditions. Following a neuroscience-informed assessment, Synchrony Brain Health® Utilizes research-validated neuromodulation technologies to achieve maximum symptom relief and support optimal brain health.
Diagnosis is established through the use of the Structured Clinical Interview for Diagnosis, or SCID, which is the most reliable and valid method of determining psychiatric diagnosis. A convergence of other data then supports the SCID in determining diagnosis. Including a variety of psychometric instruments, as well as functional neuroimaging through the use of quantitative electroencephalography (qEEG).